US Bancorp DE Invests $96,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

US Bancorp DE purchased a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHFree Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 2,224 shares of the company’s stock, valued at approximately $96,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. SVB Wealth LLC acquired a new position in shares of SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $267,000. Sigma Planning Corp purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $221,000. Arlington Financial Advisors LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $291,000. Kingsview Wealth Management LLC purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter worth about $11,388,000. Finally, First Citizens Bank & Trust Co. boosted its position in shares of SPDR S&P Pharmaceuticals ETF by 77.2% in the 4th quarter. First Citizens Bank & Trust Co. now owns 127,696 shares of the company’s stock worth $5,490,000 after buying an additional 55,643 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Up 0.8 %

SPDR S&P Pharmaceuticals ETF stock opened at $42.95 on Monday. SPDR S&P Pharmaceuticals ETF has a 52 week low of $38.88 and a 52 week high of $48.76. The firm’s 50-day simple moving average is $44.30 and its 200 day simple moving average is $44.77. The firm has a market capitalization of $154.62 million, a PE ratio of 15.01 and a beta of 0.72.

SPDR S&P Pharmaceuticals ETF Profile

(Free Report)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Articles

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPHFree Report).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.